Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of the Serum Gamma-Glutamyl Transferase and Serum Uric Acid Levels according to the Obesity Types Based upon on the Body Mass Index in Korean Men

성인 남성에서 체질량지수로 분류한 비만 유형에 따른 혈청 감마 글루타밀 전이효소와 혈청 요산농도의 차이 비교

  • Shin, Kyung A (Department of Clinical Laboratory Science, Shinsung University)
  • Received : 2018.11.08
  • Accepted : 2018.12.02
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study examined the relationship between the serum GGT (gamma-glutamyl transferase) and uric acid level in obese male adults. A total of 14,283 adult males aged 20 years or more, who visited the health examination center of Gyeonggi Regional General Hospital from January 2017 to August 2018 and underwent a physical examination, were enrolled in this study. The obesity criteria were defined by the Asia-Pacific regional standards. Abdominal obesity was defined as a male waist circumference of more than 90 cm. An increase in the serum uric acid and serum CGT levels of the male subjects was defined as 7.0 mg/dL or more and 56 IU/L or more, respectively. The results showed that the serum GGT and uric acid levels were higher in the overweight and obese groups than in the normal weight group. In the obese group, the serum GGT and uric acid were significantly higher in the patients with abdominal obesity. On the other hand, there was no difference compared to the low body weight group. The overweight and obesity groups showed a higher risk of elevated serum GGT and hyperuricemia than the normal weight group, but a low body weight did not affect the serum GGT elevation and hyperuricemia. Overall, the serum GGT and uric acid levels are useful for evaluating overweight and obesity in adult males.

본 연구는 성인 남성을 대상으로 체질량지수로 분류한 비만 유형에 따른 혈청 GGT와 요산농도의 차이와 관련성을 확인하고자 하였다. 2017년 1월부터 2018년 8월까지 경기지역 종합병원의 건강검진센터를 내원하여 건강검진을 실시한 20세 이상 성인 남성 14,283명을 대상으로 하였다. 비만 기준은 아시아-태평양지역 기준을 적용하였으며, 복부비만은 남성의 허리둘레 90 cm이상을 기준치로 정의하였다. 남성 대상자의 혈청 요산농도 상승은 7.0 mg/dL 이상, 혈청 GGT 상승은 56 IU/L 이상으로 정의하였다. 본 연구결과 혈청 GGT와 요산농도는 정상체중군보다 과체중과 비만군에서 높았으며, 비만군에서는 복부비만을 동반한 경우 혈청 GGT ($53.26{\pm}49.67IU/L$ vs $67.66{\pm}60.16IU/L$) 및 요산농도($6.22{\pm}1.26mg/dL$ vs $6.38{\pm}1.40mg/dL$)가 유의하게 높았다. 그러나 저체중군과는 차이가 없었다. 또한 과체중과 비만군은 정상체중군보다 혈청 GGT 상승과 고요산혈증의 위험이 높게 나타났으나, 저체중은 혈청 GGT 상승과 고요산혈증에 영향을 미치지 않는 것으로 나타났다. 따라서 성인 남성의 과체중 및 비만을 평가하는데 혈청 GGT와 요산이 유용하다고 판단된다.

Keywords

References

  1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263-355. https://doi.org/10.1080/20014091084227
  2. Wu J, Qiu L, Yan WH, Cheng XQ, Wu W, Guo XZ, et al. Serum gamma-glutamyl transferase and uric acid levels are associated with impaired fasting glucose in adults from Inner Mongolia, China. BMC Public Health. 2013;13:294. https://doi.org/10.1186/1471-2458-13-294
  3. Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res. 2005;37:246-251. https://doi.org/10.1055/s-2005-861411
  4. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyl transferase and diabetes-a 4 year follow-up study. Diabetologia. 2003;46:359-364. https://doi.org/10.1007/s00125-003-1036-5
  5. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2005;25:193-197. https://doi.org/10.1161/01.ATV.0000148324.63685.6a
  6. Yunus YM, Muniandy W, Lai HI. Comparison of serum uric acid and gamma-glutamyl transpeptidase (GGT) level in obese individuals and non-obese individual. Int J Acad Res Bus Soc Sci. 2017;7:756-769.
  7. Feig DI, Madero M, Jalal DI, Sanchez-Lozada LG, Johnson RJ. Uric acid and the origins of hypertension. J Pediatr. 2013;162:896-902. https://doi.org/10.1016/j.jpeds.2012.12.078
  8. Qin L, Yang Z, Gu H, Lu S, Shi Q, Xing Y, et al. Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovasc Disord. 2014;14:26. https://doi.org/10.1186/1471-2261-14-26
  9. Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C. Crosssectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012;41:450-457. https://doi.org/10.1007/s12020-012-9629-8
  10. Shin KA. Clinical usefulness of serum uric acid and resting heart rate in the diagnosis of metabolic syndrome in Korean adults. Biomedical Science Letters. 2017;23:118-127. https://doi.org/10.15616/BSL.2017.23.2.118
  11. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290:625-631. https://doi.org/10.1152/ajprenal.00140.2005
  12. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007;293:584-596. https://doi.org/10.1152/ajpcell.00600.2006
  13. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005-1015. https://doi.org/10.2337/diabetes.51.4.1005
  14. Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350:1220-1234. https://doi.org/10.1056/NEJMra025261
  15. WHO; IASO; IOTF. The Asia-Pacific perspective: redefining obesity and its treatment [Internet]. Sydney: Australia; 2000 [cited 2018 September 10]. Available from: http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf.
  16. Kang DH. Does hyperuricemia play a causative role in the development and/or aggravation of renal, cardiovascular and metabolic disease? Korean J Med. 2011;80:524-528.
  17. Jalanko H, Ranta T, Lehtonen E, Ruoslahti E. Gamma-glutamyl transpeptidase in human amniotic fluid and in fetal tissues. Clin Chim Acta. 1983;134:337-346. https://doi.org/10.1016/0009-8981(83)90372-8
  18. Aksakal E, Tanboga IH, Kurt M, Kaygin MA, Kaya A, Isik T, et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis. 2012;221:596-601. https://doi.org/10.1016/j.atherosclerosis.2012.01.044
  19. Dogan A, Icli A, Aksoy F, Varol E, Erdogan D, Ozaydin M, et al. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events. Coron Artery Dis. 2012;23:39-44. https://doi.org/10.1097/MCA.0b013e32834e4ed0
  20. Akpek M, Elcik D, Kalay N, Yarlioglues M, Dogdu O, Sahin O, et al. The prognostic value of serum gamma-glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology. 2012;63:579-585. https://doi.org/10.1177/0003319711431880
  21. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005;20:1825-1832. https://doi.org/10.1111/j.1440-1746.2005.04058.x
  22. Lee KS, Kim KH, Cho YC. Prevalence of fatty liver and its association with indices of obesity, liver function and hyperlipidemia among adult males. J Korea Acad Industr Coop Soc. 2009;10:1414-1423. https://doi.org/10.5762/KAIS.2009.10.6.1414
  23. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844-1850. https://doi.org/10.2337/diabetes.50.8.1844
  24. Yokoyama H, Hirose H, Moriya S, Saito I. Significant correlation between insulin resistance and serum gamma-glutamyl transpeptidase (gamma-GTP) activity in non-drinkers. Alcohol Clin Exp Res. 2002;26(8 Suppl):91-94.
  25. Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum gamma- glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J Clin Endocrinol Metab. 2006;91:1419-1422. https://doi.org/10.1210/jc.2005-1783
  26. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-1821. https://doi.org/10.1056/NEJMra0800885
  27. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism. 2006;55:1293-1301. https://doi.org/10.1016/j.metabol.2006.05.013
  28. Ya Z, Fei L, Yue Z, Dan L, Neng-Bo L, Yi L, et al. Association between serum gamma-glutamyl transferase and serum uric acid levels in Chinese females: a cross-sectional study. Endocr Res. 2017;42:296-301. https://doi.org/10.1080/07435800.2017.1300809
  29. Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288:27138-27149. https://doi.org/10.1074/jbc.M113.485094
  30. Hong SJ, Kim YS, Kim HS. Prevalence and clinical features of hyperuricemia in Gwangju and Jeonnam territories. J Rheum Dis. 2012;19:138-146. https://doi.org/10.4078/jrd.2012.19.3.138
  31. Kim MS, Moon YT, Kim MS. The relationship between obesity and the risk factors of urolithiasis. Korean J Urol. 2007;48:505-511. https://doi.org/10.4111/kju.2007.48.5.505
  32. Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS One. 2018;13:e0206850. https://doi.org/10.1371/journal.pone.0206850
  33. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555-563. https://doi.org/10.1111/j.1365-2796.2003.01229.x
  34. Yano K, Rhoads G, Kagan A. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis. 1977;30:171-184. https://doi.org/10.1016/0021-9681(77)90083-2
  35. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61:225-232. https://doi.org/10.1002/art.24164
  36. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 2008;54:273-284. https://doi.org/10.1373/clinchem.2007.094425
  37. Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 2012;17:656-669. https://doi.org/10.2741/3950
  38. Folsom AR, Burke GL, Ballew C, Jacobs DR Jr, Haskell WL, Donahue RP, et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin. Am J Epidemiol. 1989;130:911-924. https://doi.org/10.1093/oxfordjournals.aje.a115424
  39. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007;293:1118-1128. https://doi.org/10.1152/ajpendo.00435.2007
  40. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell. 1996;87:377-389. https://doi.org/10.1016/S0092-8674(00)81359-8

Cited by

  1. 비만하지 않은 성인 남성에서 대사증후군의 대리 표지자로서 감마 글루타밀 전이효소의 임상적 유용성 평가 vol.10, pp.12, 2019, https://doi.org/10.22156/cs4smb.2020.10.12.146